Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Madrigal Pharmaceuticals (MDGL) Gross Profit: 2009-2024

Historic Gross Profit for Madrigal Pharmaceuticals (MDGL) over the last 13 years, with Dec 2024 value amounting to $173.9 million.

  • Madrigal Pharmaceuticals' Gross Profit rose 362.03% to $287.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $740.6 million, marking a year-over-year increase of 973.33%. This contributed to the annual value of $173.9 million for FY2024, which is 1468.00% up from last year.
  • As of FY2024, Madrigal Pharmaceuticals' Gross Profit stood at $173.9 million, which was up 1,468.00% from -$12.7 million recorded in FY2023.
  • In the past 5 years, Madrigal Pharmaceuticals' Gross Profit registered a high of $173.9 million during FY2024, and its lowest value of -$12.7 million during FY2023.
  • Its 3-year average for Gross Profit is $52.4 million, with a median of -$4.0 million in 2022.
  • Its Gross Profit has fluctuated over the past 5 years, first crashed by 1,552.01% in 2022, then soared by 1,468.00% in 2024.
  • Over the past 5 years, Madrigal Pharmaceuticals' Gross Profit (Yearly) stood at $100,000 in 2020, then soared by 173.00% to $273,000 in 2021, then crashed by 1,552.01% to -$4.0 million in 2022, then tumbled by 220.69% to -$12.7 million in 2023, then skyrocketed by 1,468.00% to $173.9 million in 2024.